THOMAS COX: Open Payments
NPI 1770502387 · CEDAR SPRINGS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 48 payments from 19 companies in 2025. Trend: 2023 $919 · 2024 $1,049 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $104 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Novo Nordisk Inc | 4 | $96 |
| ABBVIE INC. | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Supernus Pharmaceuticals, Inc. | 5 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Lilly USA, LLC | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: REXULTI, TRELEGY ELLIPTA, AIRSUPRA, Qelbree, PREVNAR 20, CAPLYTA, VRAYLAR, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
